Bumrungrad Hospital PCL (BUHPF)
6.93
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Bumrungrad Hospital Price to Book Value: 7.757 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 7.757 |
| May 16, 2024 | 7.757 |
| May 15, 2024 | 7.679 |
| May 14, 2024 | 7.679 |
| May 13, 2024 | 7.679 |
| May 10, 2024 | 6.828 |
| May 09, 2024 | 6.828 |
| May 08, 2024 | 6.828 |
| May 07, 2024 | 6.828 |
| May 06, 2024 | 6.828 |
| May 03, 2024 | 6.828 |
| May 02, 2024 | 6.828 |
| May 01, 2024 | 6.828 |
| April 30, 2024 | 6.828 |
| April 29, 2024 | 6.828 |
| April 26, 2024 | 6.828 |
| April 25, 2024 | 6.828 |
| April 24, 2024 | 6.828 |
| April 23, 2024 | 6.784 |
| April 22, 2024 | 6.784 |
| April 19, 2024 | 6.784 |
| April 18, 2024 | 6.784 |
| April 17, 2024 | 6.784 |
| April 16, 2024 | 6.784 |
| April 15, 2024 | 6.784 |
| Date | Value |
|---|---|
| April 12, 2024 | 6.784 |
| April 11, 2024 | 6.784 |
| April 10, 2024 | 6.784 |
| April 09, 2024 | 6.784 |
| April 08, 2024 | 6.784 |
| April 05, 2024 | 6.784 |
| April 04, 2024 | 6.784 |
| April 03, 2024 | 6.784 |
| April 02, 2024 | 6.784 |
| April 01, 2024 | 6.784 |
| March 31, 2024 | |
| March 28, 2024 | 7.386 |
| March 27, 2024 | 7.386 |
| March 26, 2024 | 7.386 |
| March 25, 2024 | 7.386 |
| March 22, 2024 | 7.386 |
| March 21, 2024 | 7.386 |
| March 20, 2024 | 7.386 |
| March 19, 2024 | 7.386 |
| March 18, 2024 | 7.386 |
| March 15, 2024 | 7.386 |
| March 14, 2024 | 7.386 |
| March 13, 2024 | 7.386 |
| March 12, 2024 | 7.386 |
| March 11, 2024 | 7.386 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.930
Minimum
Feb 26 2020
11.18
Maximum
Nov 10 2022
7.004
Average
7.210
Median
Feb 28 2022
Price to Book Value Benchmarks
| Bangkok Dusit Medical Services PCL | 4.470 |
| NewGenIvf Group Ltd | -- |
| CEL-SCI Corp | 4.808 |
| AIM ImmunoTech Inc | 2.107 |
| IGC Pharma Inc | 3.942 |
Price to Book Value Related Metrics
| PE Ratio | 28.65 |
| PS Ratio | 8.214 |
| PEG Ratio | 1.037 |
| Price to Free Cash Flow | 36.22 |
| Price | 6.93 |
| Earnings Yield | 3.49% |
| Market Cap | 5.509B |
| PEGY Ratio | 0.9723 |
| Operating PE Ratio | 23.73 |
| Normalized PE Ratio | 28.78 |